Effect of 8 weeks of 4D pro training on blood coagulation and non-coagulation factors in inactive overweight women

Effect of 8 weeks of 4D pro training on blood coagulation and non-coagulation factors in inactive overweight women: a before-after clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N471

Enrollment

Registered

2023-04-18

Start date

2023-05-05

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and obesity. Overweight and obesity

Interventions

Intervention group: D4 Pro consists of a connecting strap, main carabiner, four elastics, two height adjustment straps, two pads and two handles. 4D Pro is an attractive sports device that makes the

Eligibility

Sex/Gender

Female

Age

15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 18 to 65 years Overweight Being inactive

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding Cardiovascular diseases

Design outcomes

Primary

Measure	Time frame
Changes in plasma volume. Timepoint: Before the intervention and 8 weeks later. Method of measurement: By CBC test.;Fibrinogen level. Timepoint: Before the intervention and 8 weeks later. Method of measurement: Through Electrophoretic.;Factor 8 level. Timepoint: Before the intervention and 8 weeks later. Method of measurement: With coagulation tests.;Prothrombin time. Timepoint: Before the intervention and 8 weeks later. Method of measurement: With coagulation tests.;The number of platelets. Timepoint: Before the intervention and 8 weeks later. Method of measurement: By CBC test.	—

Measure

Time frame

Changes in plasma volume. Timepoint: Before the intervention and 8 weeks later. Method of measurement: By CBC test.;Fibrinogen level. Timepoint: Before the intervention and 8 weeks later. Method of measurement: Through Electrophoretic.;Factor 8 level. Timepoint: Before the intervention and 8 weeks later. Method of measurement: With coagulation tests.;Prothrombin time. Timepoint: Before the intervention and 8 weeks later. Method of measurement: With coagulation tests.;The number of platelets. Timepoint: Before the intervention and 8 weeks later. Method of measurement: By CBC test.

—

Secondary

Measure	Time frame
Quality of life score. Timepoint: Before the intervention and 8 weeks later. Method of measurement: Using the quality of life (QoL) questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamira Mehrabipoor

Islamic Azad University

smehrabipor@yahoo.com+98 81 3949 4000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026